The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1315-2016·Announced 2016-07-20

Pharmakon Recalls Morphine Sulfate Bags Due to Sterility Concerns

Pharmakon Pharmaceuticals is recalling 215 bags of Morphine Sulfate in Dextrose due to a lack of assurance of sterility. The affected products were distributed nationwide and to specific VA/DOD facilities.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric, particularly given the risk of infection associated with non-sterile IV products.

Plain-English summary

Pharmakon Pharmaceuticals, Inc. is recalling 215 bags of Morphine Sulfate 1 mg/mL in 5% Dextrose, 250 mL Intravia bags. The recall was initiated because of a lack of assurance of sterility for the sterile compounded products. The affected products are identified by NDC 45183-0875-02 and are compounded by Pharmakon Pharmaceuticals in Noblesville, Indiana.

The distribution of these products was nationwide, with specific shipments to VA/DOD facilities in California, Kentucky, Maryland, North Carolina, Oklahoma, Texas, and Virginia. The recall covers all sterile compounded products within their expiry dates.

Healthcare providers and patients should stop using the affected Morphine Sulfate bags and contact Pharmakon Pharmaceuticals or their local FDA office for further instructions. Consumers should not use these prescription-only products if they have been dispensed to them.

The recalled product

Product
Morphine Sulfate 1 mg/mL in 5% Dextrose, 250 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0875-02
Manufacturer
Pharmakon Pharmaceuticals, Inc.
Category
Drug — IV Compounded
Hazard
Affected units
215

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Sterile Compounded Products within Expiry

Distribution

Distributed nationwide across the United States.

The notice also names 7 states specifically:

Part of a larger recall action

This product is one of 88 recalled by Pharmakon Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 88 products in this recall →

Related recalls

Same manufacturer · Pharmakon Pharmaceuticals, Inc.

See all →

Same hazard · lack of sterility

See all →

Similar recalls